Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice (vol 8, 707, 2017) | |
Chen, Wei; Shui, Fengchun; Liu, Cheng; Zhou, Xinbo; Li, Wei; Zheng, Zhibing; Fu, Wei; Wang, Lili | |
刊名 | FRONTIERS IN PHARMACOLOGY |
2017 | |
卷号 | 8 |
关键词 | CB1R antagonist obesity periphery blood-brain-barrier |
ISSN号 | 1663-9812 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3613649 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Chen, Wei,Shui, Fengchun,Liu, Cheng,et al. Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice (vol 8, 707, 2017)[J]. FRONTIERS IN PHARMACOLOGY,2017,8. |
APA | Chen, Wei.,Shui, Fengchun.,Liu, Cheng.,Zhou, Xinbo.,Li, Wei.,...&Wang, Lili.(2017).Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice (vol 8, 707, 2017).FRONTIERS IN PHARMACOLOGY,8. |
MLA | Chen, Wei,et al."Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice (vol 8, 707, 2017)".FRONTIERS IN PHARMACOLOGY 8(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论